Literature DB >> 12007836

The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells.

Vardit Rubovitch1, Mikhal Gafni, Yosef Sarne.   

Abstract

The present study demonstrates a novel stimulatory effect of a cannabinoid agonist on calcium channels. DALN (1 nM) potentiated 45Ca(2+)-uptake by N18TG2 neuroblastoma cells, an effect that was abolished by the specific CB1 receptor antagonist SR141716A. The stimulation of 45Ca(2+)-uptake by DALN was resistant to pertussis toxin (PTX), suggesting that Gi/Go GTP-binding proteins did not mediate this effect. Furthermore, PTX unmasked a stimulatory effect of a high concentration of DALN (1 microM), which by itself failed to stimulate calcium uptake in naive cells. The stimulatory effect of DALN on calcium entry to the cells was blocked by nicardipine but not by omega-conotoxin GVIA, indicating the entry of calcium through L-type voltage-dependent calcium channels. Blocking cAMP-dependent protein kinase (PKA) by H-89 completely eliminated the elevation in calcium uptake, while blocking protein kinase C (PKC) by chelerythrine and calphostine-C only partially attenuated the stimulation. Blocking calmodulin by W-7 revealed a similar partial inhibition of the stimulatory effect of DALN. Hence, we suggest a cannabinoid-specific, PTX-insensitive, stimulatory effect on L-type voltage-dependent calcium channels, which is mediated by PKA and modulated by PKC and calmodulin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007836     DOI: 10.1016/s0169-328x(02)00174-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  15 in total

1.  Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.

Authors:  Roger Cachope; Ken Mackie; Antoine Triller; John O'Brien; Alberto E Pereda
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

2.  The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.

Authors:  Jane E Lauckner; Bertil Hille; Ken Mackie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Dual neuroprotective and neurotoxic effects of cannabinoid drugs in vitro.

Authors:  Anastasia Bologov; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Cell Mol Neurobiol       Date:  2010-11-04       Impact factor: 5.046

Review 4.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

5.  L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.

Authors:  Nima Naderi; Leila Ahmad-Molaei; Ali Mazar-Atabaki; Abdolaziz Ronaghi; Zahra Shirazi-zand; Seyed Mehrdad Motiei-Langroudi; Somayeh Eslahkar
Journal:  Neurochem Res       Date:  2011-09-18       Impact factor: 3.996

6.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

Review 7.  Signal transduction via cannabinoid receptors.

Authors:  George D Dalton; Caroline E Bass; C G Van Horn; Allyn C Howlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

8.  Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.

Authors:  Carmen Manzanedo; Marta Rodríguez-Arias; Manuel Daza-Losada; Concepción Maldonado; María A Aguilar; José Miñarro
Journal:  Behav Brain Funct       Date:  2010-03-22       Impact factor: 3.759

9.  Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.

Authors:  B Bosier; E Hermans; Dm Lambert
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

10.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.